Synthesis of xylo-LNA containing one 2′-O,4′-C-methylene-β-D-xylofuranosyl thymine nucleotide monomer and α-L-LNAs containing one or four 2′-O,4′-C-methylene-α-L-ribofuranosyl thymine nucleotide monomer(s) has been accomplished using phosphoramidite chemistry with pyridine hydrochloride as activator; oligothymidylate α-L-LNA displays strongly enhanced affinity towards complementary RNA.
No takes yet. Share an insight, caveat, or question.
Rajwanshi et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: